News
UNC researchers discover how hepatitis C virus reprograms human liver cells
Hepatitis C virus has evolved to invade and hijack the basic machinery of the human liver cell to ensure its survival and spread. Researchers at the University of North have discovered how hepatitis C binds with and repurposes a basic component of cellular metabolism known as a microRNA to help protect and replicate the virus.
Global Oncology Program holds third annual retreat
The UNC Global Oncology Program held its third annual retreat on December 14 at the Friday Center. Led by Dr. Blossom Damania, Director of the UNC Lineberger Global Oncology Program, and Dr. Dirk Dittmer, Program Resource Director for the program, close to 80 program members from the UNC Center for AIDS Research and UNC Lineberger shared their research.
Neil Hayes: A pragmatic physician/scientist
For Dr. Neil Hayes “the best part of being a scientist is the people. Here at UNC, it’s the leadership we have for the cancer center in clinical fields, the wonderful scientists across the country who we collaborate with, and our patients.”
Breast cancer survival featured on UNC's Your Health Radio
Dr. Lisa Carey, Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, and Barbara Martin, Health-e-NC Project Director, will discuss surviving breast cancer on the next episode of UNC’s Your Health with Adam & Cristy.
Caregiver support group featured on ABC 11
ABC 11 recently featured the UNC Comprehensive Cancer Support Program's Caregiver Support Group.
Oncology Program holds third annual retreat
The UNC Lineberger Geriatric Oncology Program held its third annual retreat on November 29 at the Friday Center. Program members presented research and heard scientific presentations from colleagues at Duke and Wake Forest Universities. The group then discussed areas of possible collaboration.
Ribisl to lead UNC Lineberger Cancer Prevention and Control Program
Kurt Ribisl, PhD, has been appointed to lead the Cancer Prevention and Control Program at the UNC Lineberger Comprehensive Cancer Center.
Roth study paves way to design drugs aimed at multiple protein targets
An international research collaboration led by scientists at the University of North Carolina School of Medicine and the University of Dundee, in the U.K., have developed a way to efficiently and effectively make designer drugs that hit multiple protein targets at once.
Something Blue
Brook Zickus’ wedding bouquet featured an unusual “something blue”: a UNC Lineberger ribbon-foot pin.
Basch discusses the value of patient-reported data in comparative effectiveness research in two webinars Dec. 11 and 12
Ethan Basch, MD, Director of the Cancer Outcomes Research Program at UNC Lineberger Comprehensive Cancer Center, will be speaking in two webinars on comparative effectiveness on Tuesday, Dec. 11 and Wednesday, Dec. 12.
More than 60 UNC Lineberger physicians named Best Doctors in America® 2012-2013
The annual compilation of The Best Doctors in America® includes more than 60 physicians affiliated with the University of North Carolina’s Lineberger Comprehensive Cancer Center.
Yang quoted by Fox News on gender and cancer survivability
Yang Yang, PhD, associate professor of sociology and member of UNC Lineberger, was quoted about a Journal of Urology study that found that men have a higher death rate from cancer.
Evans interviewed by NPR on genetic mutations in healthy people
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, was quoted on National Public Radio's All Things Considered discussing a report in American Journal of Human Genetics finding that healthy people have many genetic mutations.
Magnuson serves as vice-chair of report on California stem cell research
Terry Magnuson served on an Institute of Medicine commission tasked to review the progress of California’s state-funded regenerative medicine initiative focused on stem cell research.
Norman E. Sharpless appointed Deputy Director of UNC Lineberger
Chapel Hill, NC – Norman E. “Ned” Sharpless, MD, has been appointed Deputy Director of the UNC Lineberger Comprehensive Cancer Center. Dr. Sharpless is the Wellcome Distinguished Professor in Cancer Research, professor of medicine and genetics.
Innocenti receives 2013 Leon I. Goldberg Award
Federico Innocenti, MD, PhD, received the 2013 Leon I. Goldberg Young Investigator Award from the American Society for Clinical Pharmacology and Therapeutics. Innocenti, associate director for oncology research in the UNC Institute for Pharmacogenomics and Individualized Therapy and a member of UNC Lineberger, was recognized for his work in individualizing therapy for cancer patients.
Three Lineberger members named AAAS 2012 Fellows
The American Association for the Advancement of Science has awarded three UNC Lineberger Comprehensive Cancer Center members the distinction of AAAS 2012 Fellow. The three were among four UNC School of Medicine Faculty honored.
Real Nurses - Stacey Anderegg
Stacey Anderegg is an Hematology/Oncology Infusion Nurse at the N.C. Cancer Hospital. In her life outside the hospital, Stacey is a vocalist with a 7 woman a cappella group called "Stella."
Carey interviewed by MedPage Today about African Americans and breast cancer
Dr. Lisa Carey, MD, medical director of the UNC Breast Center and associate director for clinical science at UNC Lineberger Comprehensive Cancer Center, spoke to MedPage Today about a recent Centers for Disease Control study that reported that black patients had a 41 percent higher mortality than their white counterparts, despite having a lower incidence of the disease.
New mechanism for cancer progression discovered by UNC and Harvard researchers
The protein Ras plays an important role in cellular growth control. Researchers have focused on the protein because mutations in its gene are found in more than 30 percent of all cancers, making it the most prevalent human oncogene.
